Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Silberbauer

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Wiener Klinische Wochenschrift|February 3, 1984
[Technic of radioactive labeling of autologous human thrombocytes using 111-indium-oxine and 111-indium-oxine-sulfate and their clinical use]E Jäger, H Kolbe, K Silberbauer, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1981
Standardized ergometer exercise in trained rowers: effect on reversible platelet microaggregates and platelet aggregationK Silberbauer, H Sinzinger, P Haber, et al.
Chest|July 1, 1986
Platelet sensitivity to prostacyclin in smokers and non-smokersO C Burghuber, C Punzengruber, H Sinzinger, et al.
The New England Journal of Medicine|February 15, 1979
Decreased vascular prostacyclin in juvenile-onset diabetesK Silberbauer, G Schernthaner, H Sinzinger, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1979
[Juvenile diabetes mellitus: decreased prostacyclin (PGI2) synthesis in the vascular wall]K Silberbauer, G Schernthaner, H Sinzinger, et al.
Wiener Medizinische Wochenschrift (1946)|July 17, 1999
[Prevention of coronary heart diseases in clinical practice. Comment on the recommendations of the Second Joint Task Force of European Societies for Prevention of Coronary Disease]W Klein, G Maurer, J R Patsch, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1981
Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathyG Schernthaner, H Sinzinger, K Silberbauer, et al.
Acta Medica Austriaca. Supplement|January 1, 1979
[Thrombocyte function and systemic effect of prostaglandin I2 inhalation]K Silberbauer, H Sinzinger, O Burghuber, et al.
Thrombosis and Haemostasis|August 31, 1979
Prostacyclin activity is diminished in different types of morphologically controlled human atherosclerotic lesionsH Sinzinger, K Silberbauer, W Feigl, et al.
Experimentelle Pathologie|January 1, 1980
Prostacyclin (PGI2)-generation by different types of human atherosclerotic lesionsH Sinzinger, W Feigl, K Silberbauer, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Wiener Klinische Wochenschrift|February 3, 1984
[Technic of radioactive labeling of autologous human thrombocytes using 111-indium-oxine and 111-indium-oxine-sulfate and their clinical use]E Jäger, H Kolbe, K Silberbauer, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1981
Standardized ergometer exercise in trained rowers: effect on reversible platelet microaggregates and platelet aggregationK Silberbauer, H Sinzinger, P Haber, et al.
Chest|July 1, 1986
Platelet sensitivity to prostacyclin in smokers and non-smokersO C Burghuber, C Punzengruber, H Sinzinger, et al.
The New England Journal of Medicine|February 15, 1979
Decreased vascular prostacyclin in juvenile-onset diabetesK Silberbauer, G Schernthaner, H Sinzinger, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1979
[Juvenile diabetes mellitus: decreased prostacyclin (PGI2) synthesis in the vascular wall]K Silberbauer, G Schernthaner, H Sinzinger, et al.
Wiener Medizinische Wochenschrift (1946)|July 17, 1999
[Prevention of coronary heart diseases in clinical practice. Comment on the recommendations of the Second Joint Task Force of European Societies for Prevention of Coronary Disease]W Klein, G Maurer, J R Patsch, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1981
Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathyG Schernthaner, H Sinzinger, K Silberbauer, et al.
Acta Medica Austriaca. Supplement|January 1, 1979
[Thrombocyte function and systemic effect of prostaglandin I2 inhalation]K Silberbauer, H Sinzinger, O Burghuber, et al.
Thrombosis and Haemostasis|August 31, 1979
Prostacyclin activity is diminished in different types of morphologically controlled human atherosclerotic lesionsH Sinzinger, K Silberbauer, W Feigl, et al.
Experimentelle Pathologie|January 1, 1980
Prostacyclin (PGI2)-generation by different types of human atherosclerotic lesionsH Sinzinger, W Feigl, K Silberbauer, et al.
Pageof 12